
James Economou
Chief, Surgical Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · ·
History
PresentSurgical Oncology Division · UCLA David Geffen School of Medicine/UCLA Medical Center





- 1976–1980
Research
Technical details of intraoperative lymphatic mapping for early stage melanoma
Archives of Surgery · 1992 · 3,350 citations
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes
The Journal of Immunology · 1989 · Last of 5 authors · 497 citations
Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors
Journal of Vascular and Interventional Radiology · 2003 · 378 citations

54 papers

39 papers
- DM
9 papers

8 papers

8 papers · 8 as a resident

8 papers · 8 as a resident

6 papers

6 papers
Grants
- 2007–2013
Pet Imaging of Mart Tcr-Engineered cd8 t Cell Immunotherapy in Man
National Cancer Institute · R01
Contact PI · $1.4M · University of California Los Angeles
- 1997–2008
UCLA Clinical Scientist Training in Cancer Gene Medicine
National Cancer Institute · K12
Contact PI · $3.8M · University of California Los Angeles
- 1999–2008
Dendritic Cell-Based Genetic Immunotherapy for Melanoma
National Cancer Institute · R01
Contact PI · $2.8M · University of California Los Angeles
- 1997–2007
Ucla Cancer Gene Medicine Training Program
National Cancer Institute · T32
Contact PI · $1.7M · University of California Los Angeles
Clinical trials
- 2009–2019
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
- 2007–2015
Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
- 2001–2008
Vaccine Therapy in Treating Patients With Liver Cancer
Principal investigator · Completed · Phase 1, Phase 2
Jonsson Comprehensive Cancer Center
- 2002–2009
Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
Study chair · Completed · Phase 1, Phase 2
Jonsson Comprehensive Cancer Center



